Abstract
Age-related macular degeneration (AMD) is a common sight-threatening disease of older adults and treatment options are needed. Abnormalities of retinal pigment epithelium (RPE), supporting cells to photoreceptors and capillaries, are a hallmark. Clinical optical coherence tomography (OCT) imaging reveals hyperreflective foci (HRF) that confer risk for end-stage disease and are attributed to ectopic out-of-layer RPE. Using longitudinal OCT imaging of AMD patients, we demonstrate that the trajectory of one HRF form, RPE plume, parallels the retinal Henle fiber layer. Histology shows fully pigmented cells approaching and contacting retinal capillaries with RPE organelles dispersing along Müller glia columns. We used immunohistochemistry and a system of morphologic phenotypes to assess RPE functional repertoire in AMD. RPE corresponding to HRF loses immunoreactivity for retinoid processing proteins RPE65 and CRALBP, and gains immunoreactivity for immune cell markers CD68 and CD163. Müller glia retain CRALBP immunoreactivity. Gain- and loss-of-function for RPE starts with individual in-layer cells and extends to all abnormal phenotypes. Down-regulated RPE retinoid handling may contribute to slowed rod vision while Müller glia sustain cone vision. Ectopic RPE corresponding to HRF are emblematic of widespread transdifferentiation, motivating treatments targeting AMD pathology earlier than the initiation of atrophy. Data can propel new biomarkers and therapeutic strategies for AMD.
One Sentence Summary In age-related macular degeneration retinal pigment epithelial cells transdifferentiate and migrate into the retina where they are clinically visible progression risk indicators.
Competing Interest Statement
T.A. receives research funding from Novartis and is a stockholder of MacRegen Inc. K.B.F. is a consultant to Genentech, Optovue, Zeiss, Heidelberg Engineering, Allergan, and Novartis. C.A.C. receives research funds from Genentech/ Hoffman LaRoche and Heidelberg Engineering and is a stockholder of MacRegen Inc.
Clinical Trial
n.a.
Funding Statement
This work was supported by National Institutes of Health (Bethesda, MD, USA) grant R01EY015520 (CAC); The Macula Foundation, Inc., New York, NY; an anonymous donor to AMD research at UAB; unrestricted funds to the Department of Ophthalmology from Research to Prevent Blindness, Inc.; and EyeSight Foundation of Alabama. Acquisition of human tissues for immunohistochemistry was funded by NIH grant R01EY015520 (CAC) and R01EY027948 (CAC, TA) and IZKF Würzburg (N-304, TA).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Study of a clinical cohort and use of human tissue samples was approved by institutional review board at Vitreous Macula Retina and University of Alabama at Birmingham, respectively, and complied with the Health Insurance Portability and Accountability Act of 1996 and the Declaration of Helsinki.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Available on request.
Abbreviations
- AMD
- Age-related macular degeneration
- BLamD
- basal laminar deposit
- BrM
- Bruch’s membrane
- Ch
- choroid
- ChC
- choriocapillaris
- cRORA
- complete RPE and outer retinal atrophy
- d
- drusen
- ELM
- external limiting membrane
- EZ
- ellipsoid zone
- fv scar
- fibrovascular scar
- GCL
- Ganglion cell layer
- HFL
- Henle fiber layer
- ILM
- internal limiting membrane
- IPL
- inner plexiform layer
- INL
- inner nuclear layer
- IS
- inner segments of photoreceptors
- iRORA
- complete RPE and outer retinal atrophy
- IZ
- interdigitation zone
- nvAMD
- neovascular AMD
- ONL
- outer nuclear layer
- OPL
- outer plexiform layer
- OS
- outer segments of photoreceptors
- R
- retina
- Sc
- sclera
- SRS
- subretinal space
- x
- detachment